Dr. Lopategui on the Evolution of Molecular Testing in NSCLC

preview_player
Показать описание
Jean Lopategui, MD, associate professor of pathology and director of Translational Genomics and of the Molecular Genetics Pathology Fellowship at Cedars-Sinai, discusses the evolution of molecular testing in non–small cell lung cancer (NSCLC).
Рекомендации по теме